GASTROINTESTINAL CANCER

The following clinical trials related to gastrointestinal cancers are available through the WPAHS. Please click on the link for more detailed information on the trial. Below each trial is the contact information at the WPAHS.

Colon and Rectal Trials

Study Title

P-5, Statin Polyp Prevention Trial in Patients with Resected Colon Cancer

 

Principal Investigator: Thomas Julian, M.D.

Please also contact study coordinator for more information:    

Gloria Flannery, RN (Phone 412-359-8379)

Internal Reference: (RC-5026/NSABP  Julian)

_____________________________________________________________

Study Title

FC-6 BMS CA 225-341 --   A Phase II Study to Determine the Surgical Conversion Rate in Patients Receiving Neoadjuvant Mfolfox7 Plus Cetuximab for Unresectable Wild-Type K-RAS Colorectal Cancer with Metastases Confined to the Liver

 

Principal Investigator: Thomas Julian, M.D.

Please also contact study coordinator for more information:    

Gloria Flannery, RN (Phone 412-359-8379)

Internal Reference: (RC-4999/NSABP  FRP   Julian)

_____________________________________________________________

Study Title

A Clinical Trial Comparing Preoperative Radiation Therapy And Capecitabine With or Without Oxaliplatin With Preoperative Radiation Therapy And Continuous Intravenous Infusion Of 5-Fluorouracil With or Without Oxaliplatin In The Treatment Of Patients With Operable Carcinoma Of The Rectum

 

Principal Investigator: Thomas Julian, M.D.

Please also contact study coordinator for more information:    

Stephanie Kinney, CRA (Phone 412-359-4856) 

Internal Reference: (RC-3769/R-04 Julian)

_____________________________________________________________

Study Title

A Randomized Phase III Study Comparing 5-FU, Leucovorin and Oxaliplatin versus 5-FU, Leucovorin, Oxaliplatin and Bevacizumab in Patients with Stage II Colon Cancer at High Risk for recurrence to Determine Prospectively the Prognostic Value of Molecular Marker

 

Principal Investigator: David Medich, M.D.

Please also contact study coordinator for more information:    

Irina Barskaya, MD, CRA (412-35- 6165)

Internal Reference: (RC- 4199/E5202   Medich)

____________________________________________________________

Study Title

A Phase III Trial of Irinotecan / 5-FU / Leucovorin or Oxaliplatin / 5-FU/ Leucovorin With Bevacizumab, or Cetuximab (C225), or With the Combination of Bevacizumab and Cetuximab for Patients With Untreated Metastatic Adenocarcinoma of the Colon or Rectum

 

Principal Investigator: John Lister, M.D.

Please also contact study coordinator for more information:    

Rich Wonder, RN, CCRC (Phone 204-8125)

Internal Reference: ( WPCI 2005-35/CALGB C 80405 Lister)

_____________________________________________________________

Study Title

A Phase III Prospective Randomized Trial Comparing Laparoscopic-assisted Resection Versus Open Resection for Rectal Cancer

 

Principal Investigator: James McCormick, M.D.

Please also contact study coordinator for more information:    

Mykie Bianchi, CCRC (Phone 412-578-4316)

Internal Reference: (WPCI 2009-19/ACOSOG Z6051 McCormick)

_____________________________________________________________

Study Title

A Clinical Trial Comparing Preoperative Radiation Therapy And Capecitabine With or Without Oxaliplatin With Preoperative Radiation Therapy And Continuous Intravenous Infusion Of 5-Fluorouracil With or Without Oxaliplatin In The Treatment Of Patients With Operable Carcinoma Of The Rectum

 

Principal Investigator: James McCormick, M.D.

Please also contact study coordinator for more information:    

Mykie Bianchi, CCRC (Phone 412-578-4316)

Internal Reference: (WPCI 2009-31/NSABP R-04  McCormick)

 



Visit the West Penn Allegheny Health System

© West Penn Allegheny Health System

Privacy Statement | Legal Disclaimer

This website is for informational purposes only and not intended as medical advice or a substitute for a consultation with a professional healthcare provider.